Amdocs Deferred Long Term Liab from 2010 to 2024

DOX Stock  USD 85.67  0.47  0.55%   
Amdocs Deferred Long Term Liabilities yearly trend continues to be fairly stable with very little volatility. Deferred Long Term Liabilities is likely to outpace its year average in 2024. Deferred Long Term Liabilities is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. View All Fundamentals
 
Deferred Long Term Liabilities  
First Reported
2010-12-31
Previous Quarter
197.5 M
Current Value
212.7 M
Quarterly Volatility
45.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Amdocs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amdocs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 181.9 M, Interest Expense of 27.9 M or Total Revenue of 3.1 B, as well as many indicators such as Price To Sales Ratio of 3.4, Dividend Yield of 0.0378 or PTB Ratio of 1.38. Amdocs financial statements analysis is a perfect complement when working with Amdocs Valuation or Volatility modules.
  
Check out the analysis of Amdocs Correlation against competitors.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

Latest Amdocs' Deferred Long Term Liab Growth Pattern

Below is the plot of the Deferred Long Term Liab of Amdocs over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Amdocs' Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amdocs' overall financial position and show how it may be relating to other accounts over time.
Deferred Long Term Liab10 Years Trend
Slightly volatile
   Deferred Long Term Liab   
       Timeline  

Amdocs Deferred Long Term Liab Regression Statistics

Arithmetic Mean248,249,420
Geometric Mean244,565,675
Coefficient Of Variation18.41
Mean Deviation41,236,520
Median219,417,000
Standard Deviation45,714,668
Sample Variance2089.8T
Range113.7M
R-Value(0.86)
Mean Square Error572.7T
R-Squared0.75
Significance0.000034
Slope(8,826,151)
Total Sum of Squares29257.6T

Amdocs Deferred Long Term Liab History

2024212.7 M
2023197.5 M
2016219.4 M
2015227.1 M
2014306 M

About Amdocs Financial Statements

Amdocs investors use historical fundamental indicators, such as Amdocs' Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Amdocs. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Deferred Long Term Liabilities197.5 M212.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Amdocs Stock Analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.